For Some Prostate Cancer Patients, Combo Treatment Improves Survival (HealthDay)

HealthDay – WEDNESDAY, July 13 (HealthDay News) — For men who have prostate
cancer that’s considered “intermediate risk,” radiation plus four months
of hormone therapy appears to improve survival, a new study finds.